154 related articles for article (PubMed ID: 12434519)
1. The bovine pineal gland contains delta and mu but not kappa or ORL1 opioid receptor subtypes.
Govitrapong P; Sawlom S; Chetsawang B; Sangchot P; Ebadi M
Proc West Pharmacol Soc; 2002; 45():32-5. PubMed ID: 12434519
[No Abstract] [Full Text] [Related]
2. The presence of delta and mu-, but not kappa or ORL(1) receptors in bovine pinealocytes.
Govitrapong P; Sawlom S; Ebadi M
Brain Res; 2002 Sep; 951(1):23-30. PubMed ID: 12231452
[TBL] [Abstract][Full Text] [Related]
3. The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis.
Chuchuen U; Ebadi M; Govitrapong P
J Pineal Res; 2004 Nov; 37(4):223-9. PubMed ID: 15485547
[TBL] [Abstract][Full Text] [Related]
4. L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors.
Sbrenna S; Marti M; Morari M; Calo G; Guerrini R; Beani L; Bianchi C
J Pharmacol Exp Ther; 1999 Dec; 291(3):1365-71. PubMed ID: 10565862
[TBL] [Abstract][Full Text] [Related]
5. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid.
Shavali S; Ho B; Govitrapong P; Sawlom S; Ajjimaporn A; Klongpanichapak S; Ebadi M
Brain Res Bull; 2005 Jan; 64(6):471-9. PubMed ID: 15639542
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M
Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
Newman LC; Sands SS; Wallace DR; Stevens CW
J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
[TBL] [Abstract][Full Text] [Related]
8. Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene.
Clarke S; Chen Z; Hsu MS; Pintar J; Hill R; Kitchen I
Brain Res; 2001 Jul; 906(1-2):13-24. PubMed ID: 11430857
[TBL] [Abstract][Full Text] [Related]
9. Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.
Zaveri NT; Journigan VB; Polgar WE
ACS Chem Neurosci; 2015 Apr; 6(4):646-57. PubMed ID: 25635572
[TBL] [Abstract][Full Text] [Related]
10. Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
Ananthan S; Khare NK; Saini SK; Davis P; Dersch CM; Porreca F; Rothman RB
Bioorg Med Chem; 2003 Sep; 11(18):4143-54. PubMed ID: 12927876
[TBL] [Abstract][Full Text] [Related]
11. Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans.
Monory K; Greiner E; Sartania N; Sallai L; Pouille Y; Schmidhammer H; Hanoune J; Borsodi A
Life Sci; 1999; 64(22):2011-20. PubMed ID: 10374926
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
14. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
Sim LJ; Childers SR
J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
[TBL] [Abstract][Full Text] [Related]
15. Changes in spinal delta and kappa opioid systems in mice deficient in the A2A receptor gene.
Bailey A; Ledent C; Kelly M; Hourani SM; Kitchen I
J Neurosci; 2002 Nov; 22(21):9210-20. PubMed ID: 12417646
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
[TBL] [Abstract][Full Text] [Related]
17. Novel molecular targets of dezocine and their clinical implications.
Liu R; Huang XP; Yeliseev A; Xi J; Roth BL
Anesthesiology; 2014 Mar; 120(3):714-23. PubMed ID: 24263237
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor binding.
Feigenbaum JJ; Simantov R
Neurosci Lett; 1996 Jul; 212(1):5-8. PubMed ID: 8823749
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
Lester PA; Traynor JR
Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
[TBL] [Abstract][Full Text] [Related]
20. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.
Husbands SM; Neilan CL; Broadbear J; Grundt P; Breeden S; Aceto MD; Woods JH; Lewis JW; Traynor JR
Eur J Pharmacol; 2005 Feb; 509(2-3):117-25. PubMed ID: 15733546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]